Imatinib Mesylate and Temozolomide in Treating Patients With Malignant Glioma

Clinical trial NCT00354068 · COMPLETED

Trial details

NCT number: NCT00354068
Sponsor: Duke University
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Brain and Central Nervous System Tumors

Start date: 2004-07-01
Primary completion: 2008-11-01
Enrollment: 65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.